Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q2 organic sales growth of 5.8% exceeded the company's 3% outlook, a later update cited a higher adjusted EPS outlook, and shares closed above their prior period peak.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Cash Flow ⢠Improving Margins ⢠Elevated Leverage CHD delivers strong margins and cash conversion, but elevated valuation, leverage, and intangible exposure warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Lower-price trend ⢠Key support holding ⢠Resistance overhead Support Level: $93.94â$94.15 Resistance Level: $95.50â$96.00 CHD is cautiously bearish after falling 2.7% over the last month from a $102.86 peak and remaining below its moving average; watch $93.94â$94.15 support versus $95.50â$96.00 resistance, with a break below support signaling downside and a move above $98.50â$99.80 improving momentum.
Sentiment & News
Key News Insights: ⢠Institutional Accumulation ⢠Bullish Research ⢠Insider Activity Church & Dwight drew strong institutional buying and bullish upside attention, though insider option-related selling warrants monitoring.
AI Summary
CHD has shifted from a defensive compounder to an execution-sensitive premium story: its 4%â5% organic-growth and 100â120 bp margin-expansion targets can justify upside only if sustained, while a >30x earnings valuation leaves little room for cost pressure, Zicam-related brand risk, or weaker volumesâwait for proof of delivery and a recovery above ~$98.50.
Description
Church & Dwight manufactures and sells household, personal care and specialty products through three reporting segments: Consumer Domestic, Consumer International and Specialty Products Division. Its consumer portfolio includes established brands across baking-soda based household goods, oral and personal care, cleaning agents, sexual and reproductive health, supplements and pet products, while its specialty business supplies animal productivity and nutritional inputs such as MEGALAC, BIO-CHLOR and CELMANAX to agricultural customers. The company distributes products via supermarkets, mass merchants, drugstores, specialty retailers, e-commerce and industrial distributors; it was founded in 1846 and is headquartered in Ewing, New Jersey.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Oct 9 | Oct 16 | CHD | Church & Dwight Co., Inc. | Q2 organic sales growth of 5.8% exceeded the company's 3% outlook, a later update cited a higher adjusted EPS outlook, and shares closed above their prior period peak. | Closed | +6.5% |
| Jan 29 | Feb 5 | CHD | Church & Dwight Co., Inc. | Church & Dwight shows moderate short-term upside with strong brand momentum, 7.3% price rise recently, stable technicals, organic growth, and upcoming Q4 2025 earnings, but tempered by premium valuation and sector challenges. | Closed | +9.4% |